LUPPINO, ILEANA MARIA
 Distribuzione geografica
Continente #
AS - Asia 92
NA - Nord America 80
EU - Europa 57
SA - Sud America 30
AF - Africa 3
OC - Oceania 2
Totale 264
Nazione #
US - Stati Uniti d'America 76
SG - Singapore 36
IT - Italia 26
BR - Brasile 25
VN - Vietnam 20
CN - Cina 15
DE - Germania 13
GB - Regno Unito 7
IN - India 6
BD - Bangladesh 3
FI - Finlandia 3
NL - Olanda 3
AU - Australia 2
CA - Canada 2
IQ - Iraq 2
IR - Iran 2
NP - Nepal 2
PH - Filippine 2
PL - Polonia 2
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
EC - Ecuador 1
FR - Francia 1
GA - Gabon 1
JP - Giappone 1
MA - Marocco 1
MX - Messico 1
NI - Nicaragua 1
PY - Paraguay 1
SA - Arabia Saudita 1
TH - Thailandia 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 264
Città #
San Jose 21
Singapore 17
Ashburn 14
Chicago 10
Ho Chi Minh City 10
Munich 9
London 6
Los Angeles 6
Rome 6
Bengaluru 5
Hefei 5
Naples 5
Dallas 4
Hanoi 4
Santa Clara 4
Beijing 3
Turku 3
Cosenza 2
Mascalucia 2
Montreal 2
Sydney 2
Turin 2
Warsaw 2
Alberton 1
Aracaju 1
Atlanta 1
Baku 1
Basra 1
Belo Horizonte 1
Belém 1
Betim 1
Biên Hòa 1
Borgia 1
Bremen 1
Brumadinho 1
Buxy 1
Can Tho 1
Ciudad Nezahualcoyotl 1
Colorado 1
Da Nang 1
Dhaka 1
Elizabeth City 1
Encarnación 1
Estación Colina 1
Glendale 1
Guayaquil 1
Hyderabad 1
Itajubá 1
Jaboatão dos Guararapes 1
Jaguarão 1
Jeddah 1
José Bonifácio 1
Kathmandu 1
Lagoa de Dentro 1
Lapu-Lapu City 1
Libreville 1
Managua 1
Manaus 1
Milan 1
Monte Aprazível 1
Montenegro 1
Montevideo 1
New York 1
Nuremberg 1
Osasco 1
Paracambi 1
Pasig 1
Pelotas 1
Petrolina 1
Plymouth 1
Recife 1
Samut Sakhon 1
San Nicolás de los Arroyos 1
Santa Rosa 1
Santo André 1
Sumaré 1
São Bernardo do Campo 1
São João de Meriti 1
São Paulo 1
Tangier 1
Tokyo 1
Venice 1
Vienna 1
Vinh 1
Zakho 1
Totale 206
Nome #
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 54
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study 51
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 51
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 49
Long-Term Effectiveness and Safety of Ustekinumab in Crohn’s Disease: Results from a Large Real-Life Cohort Study 46
Impact of Endoscopic Band Ligation on Gastric Complications Associated with Portal Hypertension 14
Upadacitinib’s Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study 10
Totale 275
Categoria #
all - tutte 1.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.465


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202310 0 0 0 0 0 0 0 0 0 7 3 0
2023/202431 6 2 1 2 1 8 3 2 0 2 0 4
2024/202567 4 0 1 0 2 8 3 3 15 1 6 24
2025/2026167 12 19 16 26 20 16 21 15 11 11 0 0
Totale 275